SCHEMBL15061596

SCHEMBL15061596

CCCCCCCCC/C=C\CCCCCCCC(=O)NO

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.77
TERT O14746 3/20 0.63
PTPN1 P18031 3/20 0.63
PPARG P37231 3/20 0.63
PPARD Q03181 3/20 0.63
PPARA Q07869 3/20 0.63
CYP1A2 P05177 2/20 0.63
MAPT P10636 2/20 0.63
CYP2C19 P33261 2/20 0.63
BLM P54132 2/20 0.63
HSD17B10 Q99714 2/20 0.63
FABP4 P15090 2/20 0.63
FAAH O00519 2/20 0.63
KMT2A Q03164 2/20 0.63
GMNN O75496 1/20 0.63
USP2 O75604 1/20 0.63
LMNA P02545 1/20 0.63
POLB P06746 1/20 0.63
CYP2C9 P11712 1/20 0.63
ALOX15 P16050 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25712483 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL6891974 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL2680708 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL13400832 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL3492921 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL22190346 1.00 HSP90AA1 (0.77) HSP90AA1TERTPTPN1PPARGPPARD
Potassium SCHEMBL32681948 0.98 HSP90AA1 (0.74) HSP90AA1TERTPTPN1PPARGPPARD
SCHEMBL1928628 0.95 MEN1 (0.69) HSP90AA1PPARGPPARDPPARAMAPT
SCHEMBL3154754 0.89 CNR1 (0.71) PPARGPPARDPPARAMAPTBLM
SCHEMBL9319819 0.89 HSP90AA1 (0.59) HSP90AA1PPARGPPARDPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470342-B2 Methods of altering an immune response induced by CpG oligodeoxynucleotides THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-06-25 US disclosed